CIK 0001832038
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Invivyd, Inc.
Sign in to watch- Ticker
- IVVD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 851403134
- Phone
- +1 781-819-0080
- Business address
- 205 CHURCH STREET, NEW HAVEN, CT
- Former names
- Adagio Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-19 | Adimab, LLC 10% owner | Sale | −5,000,000 | $3.95 | $19.8M | 21,687,906 |
| 2022-03-03 | Adimab, LLC 10% owner | Other disposition | −1,158,089 | 26,687,906 | ||
| 2021-08-10 | Adimab, LLC 10% owner | Conversion | +25,860,700 | 27,845,995 | ||
| 2021-08-10 | Adimab, LLC 10% owner | Conversion · Series A Preferred Stock | −5,000,000 | 0 | ||
| 2021-08-10 | Adimab, LLC 10% owner | Conversion · Series B Preferred Stock | −44,076 | 0 | ||
| 2021-08-10 | Adimab, LLC 10% owner | Conversion · Series C Preferred Stock | −128,064 | 0 |
Page 1 of 1 · 6 trades